Literature DB >> 8751491

Donor-specific cellular immune response against human cardiac valve allografts.

F Hoekstra1, C Knoop, L Vaessen, C Wassenaar, N Jutte, E Bos, A Bogers, W Weimar.   

Abstract

We studied the presence of donor-specific T lymphocytes in explanted human cardiac valve allografts in vivo. From five of seven explants we propagated lymphocyte cultures in an interleukin-2 conditioned medium. Phenotyping revealed the presence of T-cell receptors in more than 95% of the lymphocytes obtained in each culture. Donor-specific cytotoxicity was demonstrated in three patients with known HLA status of the donor. Cytotoxicity was directed against only HLA class I in one patient, and against class I and/or class II in the others. These results indicate that donor-specific cellular reactivity can be induced by transplantation of human cardiac valve allografts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751491     DOI: 10.1016/S0022-5223(96)70250-7

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

Review 1.  In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration.

Authors:  Benjamin Smood; Hidetaka Hara; David C Cleveland; David K C Cooper
Journal:  Ann Thorac Surg       Date:  2019-03-02       Impact factor: 4.330

2.  Increased numbers of circulating donor-specific T helper lymphocytes after human heart valve transplantation.

Authors:  M J Welters; F B Oei; L M Vaessen; A P Stegmann; A J Bogers; W Weimar
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

Review 3.  Immune Privilege of Heart Valves.

Authors:  Morgan Ashley Hill; Jennie H Kwon; Brielle Gerry; William A Hardy; Olivia Agata Walkowiak; Minoo N Kavarana; Satish N Nadig; T Konrad Rajab
Journal:  Front Immunol       Date:  2021-08-10       Impact factor: 7.561

4.  Decellularized Cryopreserved Allografts as Off-the-Shelf Allogeneic Alternative for Heart Valve Replacement: In Vitro Assessment Before Clinical Translation.

Authors:  Laura Iop; Adolfo Paolin; Paola Aguiari; Diletta Trojan; Elisa Cogliati; Gino Gerosa
Journal:  J Cardiovasc Transl Res       Date:  2017-03-09       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.